相关实验视频
Updated: Jun 6, 2025
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.5K
伊索林科菲林抑制了血小板激活和血栓形成
Yun Liu1,2, Hui Zhu2, Yue Dai2
1Department of Clinical Laboratory, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China ; and.
Journal of cardiovascular pharmacology
|December 2, 2024
概括
伊索林科菲林是一种中国草药,有效地抑制了血小板的聚合和激活. 这项研究表明,它有可能成为预防血栓和心血管疾病的新型治疗剂.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
- 心血管研究研究心血管研究
背景情况:
- 伊索林科菲林是一种著名的中国草药,具有抗炎和神经保护性质.
- 它的潜在抗血栓作用和对血小板功能的影响仍然在很大程度上未被探索.
- 了解其在血小板生物学中的作用对于潜在的治疗应用至关重要.
研究的目的:
- 为了研究伊索林科菲林的抗血栓性质.
- 评估其对人类血小板功能的影响,包括聚合,激活和信号通路.
- 在小鼠血液静止和血栓形成模型中评估其体内疗效.
主要方法:
- 人类血小板用不同度的伊索林霍菲林 (0-40μM) 进行治疗,以评估聚合,ATP分泌,P-选择素表达和αIIbβ3激活.
- 分析了血小板扩散,动员和关键信号蛋白酸化 (PLCγ2,PKCα).
- 在体内研究中,给小鼠用伊索林科菲林 (5毫克/公斤) 来评估血液静止和血栓形成模型.
主要成果:
- 伊索林科菲林表现出剂量依赖的血小板聚合,ATP分泌,P-选择素表达和αIIbβ3激活的抑制作用.
- 它减少了血小板的扩散,动员和PLCγ2和PKCα的酸化.
- 在体内,伊索林科菲林损害了血液静止,减少了动脉/静脉血栓形成,但没有影响凝血.
结论:
- 伊索林科菲林显著损害了人类的血小板功能,并减少了体内血栓形成.
- 这些发现突出了伊索林霍菲林作为一种潜在的新型治疗剂,用于治疗血栓性疾病和心血管疾病.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
01:22Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:18Structure and Function of Platelets
988
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
988
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147